A DOAC is always indicated in the acute phase of PE - PRO.

2 March 2019 (11:20 - 11:35)

Organised by:

About the speaker

Professor Felicita Andreotti

IRCCS Foundation Agostino Gemelli University Hospital, Rome (Italy)

5 More presentations in this session

Presentation thumbnail

Positioning of the topic - Old and new anticoagulants in acute pulmonary embolism

Professor F. Verheugt (Amsterdam, NL)

Presentation thumbnail

A DOAC is always recommended in the acute phase of PE - CONTRA.

Professor F. Verheugt (Amsterdam, NL)

Presentation thumbnail

A DOAC is always indicated in the acute phase of PE - Rebuttal.

Professor F. Verheugt (Amsterdam, NL) Professor F. Andreotti (Rome, IT)

Presentation thumbnail

Old and new anticoagulants in acute pulmonary embolism - Moderated discussion.

Professor F. Verheugt (Amsterdam, NL)

Presentation thumbnail

Old and new anticoagulants in acute pulmonary embolism - Conclusion.

Doctor M. Lettino (Monza, IT)

Access the full session

Session thumbnail

Old and new anticoagulants in acute pulmonary embolism: looking for the best?

The Event

Acute Cardiovascular Care 2019

2 March 2019 11:20 CET

You may be interested in

Congress Presentation

Early DOAC therapy after invasive acute pulmonary embolism therapy: fast track PE?

20 March 2026

Webinar

Antithrombotic strategy for ACS: from default to alternative strategies. ESC 2023 Clinical Practice Guidelines - Webinar Series

28 November 2023

Congress Presentation

Audience discussion.

28 August 2022

Webinar

ESC Guidelines on Acute Pulmonary Embolism ? practical guidance into clinical practice. Part 2: challenges of managing PE in the long term

11 March 2021

ESC 365 is supported by

novartis

Explore sponsored resources

novo-nordisk

Explore sponsored resources

ESC 365 is supported by

novartis

Explore sponsored resources

novo-nordisk

Explore sponsored resources